Juliane Köberlein–Neu
Biographic Data
| ID | 6779864 |
|---|---|
| NAME | Juliane Köberlein–Neu |
| GIVEN NAMES | Juliane |
| FAMILY NAME | Köberlein–Neu |
| SIGNATURE | NEU J K |
| AFFILIATIONS | University of Wuppertal |
| ORCID | 0000-0002-3451-7847 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Making data accompany the patient and prescription to improve pharmaco-therapy safety. Lessons from three aligned German initiatives
Data play key role play in prescribing and drug therapy: data on patient health and co-morbidity status, on prescribed medication, on over-the-counter (OTC) drugs and other self-medication etc. In Germany, data are not yet flowing with the patients (or the prescriptions) on their way from GP practice into pharmacy, from hospital discharge to the GP or into the nursing home or across any sectoral boundaries characterising complex care trajectories…
Coping Self-Efficacy and Its Relationship with Psychological Morbidity after Genetic Test Result Disclosure
Women who are found to carry a BRCA1/2 pathogenic variant experience psychological distress due to an increased risk of breast and ovarian cancer. They may decide between different preventive options. In this secondary analysis of data collected alongside a larger randomized controlled trial, we are looking at 130 newly found BRCA1/2 pathogenic variant carriers and how their coping self-efficacy immediately after genetic test result disclosure is…
No prominent works on this page.
Coping Self-Efficacy and Its Relationship with Psychological Morbidity after Genetic Test Result Disclosure
Women who are found to carry a BRCA1/2 pathogenic variant experience psychological distress due to an increased risk of breast and ovarian cancer. They may decide between different preventive options. In this secondary analysis of data collected alongside a larger randomized controlled trial, we are looking at 130 newly found BRCA1/2 pathogenic variant carriers and how their coping self-efficacy immediately after genetic test result disclosure is…
Making data accompany the patient and prescription to improve pharmaco-therapy safety. Lessons from three aligned German initiatives
Data play key role play in prescribing and drug therapy: data on patient health and co-morbidity status, on prescribed medication, on over-the-counter (OTC) drugs and other self-medication etc. In Germany, data are not yet flowing with the patients (or the prescriptions) on their way from GP practice into pharmacy, from hospital discharge to the GP or into the nursing home or across any sectoral boundaries characterising complex care trajectories…
Medicine (2 works) · Anxiety (1 work) · Avoidance coping (1 work) · BRCA gene mutations in cancer (1 work) · Breast cancer (1 work) · Cancer (1 work) · Clinical practice guidelines implementation (1 work) · Clinical Psychology (1 work) · Clinical Psychology (1 work) · Coping (psychology (1 work)